About Hisky
Hisky Medical

Hisky Medical, a leading innovative medical technology company originated from Tsinghua University, takes "Popularize high-end technology, Protect public health" as core mission and committed to making outstanding contributions to healthcare business. Hisky owns multiple independent research and development brands, including iLivTouch® Non-invasive Liver Disease Management System, CelTouch Confocal Microprobe lmaging Device, EQTouch High-end Ultrasound Platform, Breast Disease diagnosis & treatment solutions and so on. The product solutions cover non-invasive screening, diagnosis and post-diagnosis management in liver, digestion, endocrine, physical examination, respiratory, breast, urology, surgery and other fields.

In addition, the company has obtained more than 300 invention patents and FDA, CE, PMDA, TGA, KFDA, RZN, etc. certifications around the world, the products have been installed in 60+ countries and regions, serving millions of patients.


2
R&D Center(Jiangsu、Beijing)
Global Manufacturing Center
+
Patents applied globally
+
Units installed worldwide
Hisky Medical

Hisky Medical, a leading innovative medical technology company originated from Tsinghua University, takes "Popularize high-end technology, Protect public health" as core mission and committed to making outstanding contributions to healthcare business. Hisky owns multiple independent research and development brands, including iLivTouch® Non-invasive Liver Disease Management System, CelTouch Confocal Microprobe lmaging Device, EQTouch High-end Ultrasound Platform, Breast Disease diagnosis & treatment solutions and so on. The product solutions cover non-invasive screening, diagnosis and post-diagnosis management in liver, digestion, endocrine, physical examination, respiratory, breast, urology, surgery and other fields.

In addition, the company has obtained more than 300 invention patents and FDA, CE, PMDA, TGA, KFDA, RZN, etc. certifications around the world, the products have been installed in 60+ countries and regions, serving millions of patients.


Leadership

Corporate Culture
Our mission, vision and core values
Mission
Popularize High-end Technology
Protect Public Health
Vision
Dedicated to Becoming a Leading Enterprise in the Innovative Medical Technology Industry.
Values
Customer First
Innovation Leads to Success
Strive as the Foundation
Results Speak for Themselves
R&D Capability
Chinese national-level projects
It has contributed to key national and provincial R&D initiatives, including the 12th/13th Five-Year National Science & Technology Programs, Beijing Natural Science Foundation Key Project, and Jiangsu Provincial Technology Transfer Program.
Patent
Since it was established, the company has applied for more than 600 patents worldwide, of which over 300 are invention patents.
Historical Development
1993
Technical research
Professor Bai Jing from the Department of Biomedical Engineering of Tsinghua University conducts research on elastography technology.
2010
Hisky Medical was established.
Supported by the Key Project of the Beijing Natural Science Foundation.
2011
Supported by national and provincial sci-tech programs.
Received support from the National Twelfth Five-Year Plan for Science and Technology Support.
Received support from the Science and Technology Support Plan of Jiangsu Province.
2012
The image-guided non-invasive liver detection system was launched.
The image-guided non-invasive liver detection system was launched and obtained the certification of China's National Medical Products Administration (NMPA).
Received support from the major science and technology project of the 13th Five-Year Plan of the state.
2014
Obtained the CE certification.
The product has obtained the CE certification and the certification from TÜV SÜD institution.
The project of confocal laser microscopy endoscopy is launched.
2015
Won the Beijing Science and Technology Award.
Won the Beijing Science and Technology Award.
Received support for the science and technology achievement transformation project in Jiangsu Province.
2016
Completed the Series B corporate financing.
Completed Series B corporate financing of nearly 100 million yuan from Legend Capital and other investors.​
Selected into the "Top 100 Future Stars" list of China Entrepreneur Magazine.
2018
Obtained the certification of the U.S. Food and Drug Administration (FDA).
The product has obtained the certification of the U.S. Food and Drug Administration (FDA).
Won the Excellent Chinese Patent Award.
Won the first prize of the Hebei Provincial Science and Technology Award.
2019
Launched the MigTE® technology
The multi-modal fusion probe came out, and the sampling range reaches 1,000 times that of liver biopsy.
Won the second prize of the Jiangsu Provincial Science and Technology Award.
2020
Launched the LivQ-box® technology
Studies on non-invasive quantitative assessment technologies for NASH(MASH) have been published as cover articles in prestigious international journals.
Received support for the key special project of "Science and Technology Boosting the Economy 2020".
2021
Won the Huang Jiasi Biomedical Engineering Award.
Won the Huang Jiasi Biomedical Engineering Award, the highest award in the discipline of biomedical engineering in China.
Won the Invention Award for Patent Holders in Jiangsu Province.
2022
Won the Huaxia Medical Science and Technology Award.
Jointly won the Huaxia Medical Science and Technology Award with Beijing Friendship Hospital, Capital Medical University.
The brand was officially upgraded to iLivTouch®.
The iLivTouch® product has obtained the registration certification from Japan's Pharmaceuticals and Medical Devices Agency (PMDA).
2023
CelTouch was launched on the market.
The CelTouch confocal microprobe imaging system is officially launched on the market.
Won the Chinese Medical Science and Technology Award.
Won the Jiangsu Provincial Patent Award.
2024
MIIT-recognized "Specialized & Innovative Little Giant" Enterprise
Certified as a "Specialized, Refined, Characteristic and Innovative Little Giant" .
Winner of the China Patent Excellence Award.
Winner of the Hebei Provincial Science and Technology Progress Award (First Prize).